“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Despite not convening the Vaccines and Related Biologic Products Advisory Committee (VRBPAC) last month to vote on effectiveness and safety of the Pfizer-BioNTech COVID-19 vaccine (licensed under the name COMIRNATY), the U.S. Food and Drug Administration (FDA) convened the advisory committee on Friday, Sept. 17, 2021 to vote on booster doses of the vaccine.1 The […]
Public Health Ontario (PHO) in Canada recently released report, Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to August 7, 2021, which found that the majority of COVID-19 vaccine recipients who went to the hospital for heart inflammation after the novel vaccine were young people.1 Adolescents and young adults […]
The European Medicines Agency (EMA) last week added an autoimmune condition known as Guillain-Barré syndrome (GBS) as a possible side effect to the product information on AstraZeneca/Oxford University’s Vaxzevria (or “AZD1222”) experimental adenovirus vectored vaccine. GBS is a neurological disorder that causes pain, numbness, muscle weakness and sometimes paralysis.1 2 3 4 A total of […]
Two weeks ago, the Pfizer COVID-19 vaccine was reported as the first COVID-19 vaccine to receive full approval from the U.S. Food and Drug Administration (FDA) for individuals aged 16 and older.1 But, for some, questions remain regarding conflicting discrepancies of the wording surrounding the approval.2 While the FDA’s report states that full approval was […]
A new retrospective observational study conducted by researchers at Tel Aviv University and Maccabi Healthcare in Israel found that unvaccinated individuals who developed an infection with the SARS-CoV-2 virus were considerably more protected against the Delta variant of the virus than those who had received two doses of the Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic […]
On Aug. 23, 2021, the U.S. Food and Drug Administration (FDA) gave full approval to a Biologics License Application (BLA) submitted by BioNTech Manufacturing GmbH of Mainz, Germany on May 18, 2021 for a biologic drug called COVID Vaccine, mRNA. The FDA gave permission to BioNTech to label the product “Comirnaty” and market it in […]
Health Canada, the Canadian government’s department responsible for national health policy, earlier this month updated the product information label for Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic (also known as BNT162b2 or “Comirnaty” vaccine) to reflect reported cases of Bell’s palsy—an immune mediated neurological disorder characterized by temporary muscle weakness or paralysis on one side of […]
Opinion | It is interesting to observe the mainstream media’s reporting of the recent news that Governor Greg Abbott of Texas has tested positive for the SARS-CoV-2 virus. For example, the headline of an article by CNBC reads, “Texas Gov. Abbott, who banned mask and vaccine mandates, tests positive for Covid.” Another headline by Yahoo! News reads, “Texas […]
Singapore’s Ministry of Health (MOH) announced on Aug. 16, 2021 that it had awarded S$225,000 (just over $165,000) to the family of a 16-year-old boy in Singapore who suffered a heart attack six days after receiving the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) COVID-19 biologic (also known as BNT162b2 or “Comirnaty” vaccine) on […]
A 22-year-old man in France died on July 26, 2021 nine hours after receiving the first dose of Pfizer/BioNTech’s experimental COVID-19 biologic (also known as BNT162b2 or “Comirnaty” vaccine). Maxime Beltra was vaccinated at about 2 pm in the southern French city of Sète and then went to a local restaurant with friends. At 10 […]